article thumbnail

Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development

The Pharma Data

Lisa is a senior pharmaceutical executive with more than 20 years of experience in research and drug discovery. Kazumi Shioshaki, newly appointed Board member of Enthera, stated: “Enthera Pharmaceuticals is an exciting young biotech, with an innovative and unique approach to treating underserved autoimmune disorders. 3, 2020 08:00 UTC.

article thumbnail

Drug Discovery and Medicinal Chemistry in the Era of Automation - Webinar Recap

The Strateos Blog: Drug Discovery

Director of Chemistry of Strateos gave an interactive talk focused on how automated robotics and integrated software are powering self-driving labs that are revolutionizing synthetic chemistry to support medicinal chemistry workflows. Director of R&D Strategy and Vince Yeh, Ph.D., " - Vince Yeh, Ph.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Women in Stem with Dr Mrunal Jaywant

Drug Target Review

I worked on a project that required development of a highly sensitive method and analysis of an active pharmaceutical ingredient to determine accurate levels of two potential genotoxic impurities. We are responsible for formulating a long-term strategy for addressing nitrosamine impurities in pharmaceuticals.

article thumbnail

Re-Imagining Med Chem Strategies: the Tyranny of the n+1 Compound

DrugBaron

A lot of resources are therefore poured into synthetic chemistry, and if the compound family is at all synthetically challenging it can require dozens, even hundreds, of chemists to churn out every imaginable variant.

article thumbnail

AWS helps Pfizer accelerate drug development and clinical manufacturing

The Pharma Data

Working closely with AWS experts in machine learning and analytics, we aim to provide our scientists and researchers with the insights they need to help deliver medical breakthroughs that change patients’ lives,” said Andrew McKillop, Vice President of Pharmaceutical Sciences, Worldwide Research, Development, and Medical at Pfizer.